Showing results (351-360 of 780) with videos related to

Sort By:
Pageof 78
The New England Journal of Medicine|October 29, 1998
A randomized trial of three maintenance regimens given after three months of induction therapy with zidovudine, lamivudine, and indinavir in previously untreated HIV-1-infected patients. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study TeamG Pialoux, F Raffi, F Brun-Vezinet, et al.
Journal of Neuroradiology = Journal De Neuroradiologie|January 1, 1990
MRI pattern of progressive multifocal leukoencephalopathy (PML) in AIDS. Pathological correlationsP M Trotot, R Vazeux, H K Yamashita, et al.
Journal of Virology|January 22, 2000
Multiepitopic B- and T-cell responses induced in humans by a human immunodeficiency virus type 1 lipopeptide vaccineH Gahéry-Ségard, G Pialoux, B Charmeteau, et al.
Antimicrobial Agents and Chemotherapy|April 8, 2015
Pharmacokinetics of dolutegravir in a premature neonate after HIV treatment intensification during pregnancyJ B Pain, M P Lê, M Caseris, et al.
AIDS (London, England)|June 27, 2001
Lipopeptides induce cell-mediated anti-HIV immune responses in seronegative volunteersG Pialoux, H Gahéry-Ségard, S Sermet, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|September 3, 2008
Prevalence of hepatitis C and hepatitis B infection in the HIV-infected population of France, 2004C Larsen, G Pialoux, D Salmon, et al.
AIDS (London, England)|June 6, 2000
Efficacy and safety of combination therapy with interferon-alpha2b and ribavirin for chronic hepatitis C in HIV-infected patientsA Landau, D Batisse, J P Duong Van Huyen, et al.
AIDS Research and Human Retroviruses|March 1, 1995
A prime-boost approach to HIV preventive vaccine using a recombinant canarypox virus expressing glycoprotein 160 (MN) followed by a recombinant glycoprotein 160 (MN/LAI). The AGIS Group, and l'Agence Nationale de Recherche sur le SIDAG Pialoux, J L Excler, Y Rivière, et al.
Clinical and Experimental Immunology|November 13, 2001
CD4 T cell recovery is slower in patients experiencing viral load rebounds during HAARTD Scott-Algara, J P Aboulker, C Durier, et al.
Virology|May 1, 1993
Substitution mutations at the putative catalytic triad of the poliovirus 3C protease have differential effects on cleavage at different sitesK M Kean, M T Howell, S Grünert, et al.
Pageof 78